Marvin Martens

About Marvin Martens

Marvin Martens, With an exceptional h-index of 13 and a recent h-index of 13 (since 2020), a distinguished researcher at Universiteit Maastricht, specializes in the field of toxicology.

His recent articles reflect a diverse array of research interests and contributions to the field:

From papers to RDF-based integration of physicochemical data and adverse outcome pathways for nanomaterials

Why adverse outcome pathways need to be FAIR

WikiPathways 2024: next generation pathway database

Adverse outcome pathways coming to life: exploring new ways to support risk assessments

Linking nanomaterial-induced mitochondrial dysfunction to existing adverse outcome pathways for chemicals

Molecular adverse outcome pathways: towards the implementation of transcriptomics data in risk assessments

BridgeDb and Wikidata: a powerful combination generating interoperable open research (BridgeDb)

A community-driven, openly accessible molecular pathway integrating knowledge on malignant pleural mesothelioma

Marvin Martens Information

University

Position

PhD Candidate

Citations(all)

1997

Citations(since 2020)

1872

Cited By

685

hIndex(all)

13

hIndex(since 2020)

13

i10Index(all)

14

i10Index(since 2020)

13

Email

University Profile Page

Google Scholar

Marvin Martens Skills & Research Interests

toxicology

Top articles of Marvin Martens

From papers to RDF-based integration of physicochemical data and adverse outcome pathways for nanomaterials

Journal of Cheminformatics

2024/12

Marvin Martens
Marvin Martens

H-Index: 6

Mihaela Roxana Cimpan
Mihaela Roxana Cimpan

H-Index: 11

Why adverse outcome pathways need to be FAIR

ALTEX-Alternatives to animal experimentation

2024/1/9

WikiPathways 2024: next generation pathway database

Nucleic acids research

2024/1/5

Adverse outcome pathways coming to life: exploring new ways to support risk assessments

2024

Linking nanomaterial-induced mitochondrial dysfunction to existing adverse outcome pathways for chemicals

ALTEX-Alternatives to animal experimentation

2023/8/21

Molecular adverse outcome pathways: towards the implementation of transcriptomics data in risk assessments

bioRxiv

2023

Marvin Martens
Marvin Martens

H-Index: 6

BridgeDb and Wikidata: a powerful combination generating interoperable open research (BridgeDb)

Research Ideas and Outcomes

2022/3/7

A community-driven, openly accessible molecular pathway integrating knowledge on malignant pleural mesothelioma

Frontiers in oncology

2022/4/26

Providing adverse outcome pathways from the AOP-wiki in a semantic web format to increase usability and accessibility of the content

Applied In Vitro Toxicology

2022/3/17

Marvin Martens
Marvin Martens

H-Index: 6

Egon Willighagen
Egon Willighagen

H-Index: 30

The AOP-DB RDF: Applying FAIR principles to the semantic integration of AOP data using the research description framework

Frontiers in Toxicology

2022/2/14

Marvin Martens
Marvin Martens

H-Index: 6

Towards a qAOP framework for predictive toxicology-Linking data to decisions

Computational Toxicology

2022/2/1

COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease–3rd CIAO AOP Design Workshop

Altex

2022

Ten simple rules for creating reusable pathway models for computational analysis and visualization

2021/8/19

Metabolism and toxicity of fluorine compounds

Chemical Research in Toxicology

2021/1/29

Marvin Martens
Marvin Martens

H-Index: 6

WikiPathways: connecting communities

Nucleic acids research

2021/1/8

Intratumoral combination therapy with poly (I: C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity

Journal for immunotherapy of cancer

2021

A strategy towards the generation of testable adverse outcome pathways for nanomaterials

ALTEX-Alternatives to animal experimentation

2021

See List of Professors in Marvin Martens University(Universiteit Maastricht)

Co-Authors

academic-engine